Nanoform Finland Oyj (FRA:4YL)
Germany flag Germany · Delayed Price · Currency is EUR
0.994
+0.075 (8.16%)
At close: Dec 5, 2025

Nanoform Finland Oyj Company Description

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States.

The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances.

It also offers STARMAP, an online platform to pick winners among candidate molecules for CESS powered nanoforming.

The company was founded in 2008 and is headquartered in Helsinki, Finland.

Nanoform Finland Oyj
Country Finland
Founded 2008
Industry Commercial Physical and Biological Research
Employees 181
CEO Edward Haeggstrom

Contact Details

Address:
Cultivator II
Helsinki, 00790
Finland
Phone 358 2937 00150
Website nanoform.com

Stock Details

Ticker Symbol 4YL
Exchange Frankfurt Stock Exchange
Fiscal Year January - December
Reporting Currency EUR
SIC Code 8731

Key Executives

Name Position
Edward Haeggstrom Chief Executive Officer
Albert Haeggstrom Chief Financial Officer
Henri von Haartman Head of Investor Relations